Welcome to HArmonyCa™

Dual substance in
One Treatment

HArmonyCa™ is a dual-injectable treatment composed of hyaluronic acid and calcium hydroxyapatite.

HArmonyCa

How does HArmonyCa™ work?

Elevate your look with HArmonyCa™
HArmonyCa Product

HArmonyCa™ is a dual-effect injectable designed to be injected into the deep layers of your skin. It contains two ingredients: hyaluronic acid combined with calcium hydroxyapatite.

Why HArmonyCa™?

HACA / A / - / Icons / Circle The facial ageing is a complex process

With skin aging, a gradual loss of collagen and elastin can cause thinning and a loss of elasticity.


HACA / A / - / Icons / Circle Dual substance in One Treatment

HArmonyCa™ combines two ingredients, CaHA and HA, in one treatment.


HACA / A / - / Icons / Circle Explore Treatment

Download HArmonyCa Thai Brochure
andHArmonyCa Chinese Brochure

    Reference
  1. Allergan Aesthetics HArmonyCa™ Lidocaine IFU August 2023,
  2. Urdiales-Gálvez F, et al. J Cosmet Dermatol. 2023;00:1–12,
  3. Braz A et al. Plast Reconstr Surg Glob Open. 2024;12(2):e5622.
  4. Kahn DM and Shaw RB. Facial Plast Surg. 2010;26(5):350–55.
  5. Mills, A. (2023). Harmonyca: A first-in-class, hybrid, dual-functioning hyaluronic acid/calcium hydroxyapatite dermal filler. Journal of Aesthetic Nursing, 12(Sup8). doi:10.12968/joan.2023.12.sup8.s6
  6. Segal T, et al. 2014 – Post marketing study of safety and efficacy of Crystalys, a calcium hydroxyapatite based filler for facial soft tissue augmentation. Available at: https://www.kosmetischemedizinonline.de/uebersichtsarbeit/postmarketingstudie-zur-sicherheit-undwirksamkeit-von-crystalys-einemauf-calcium-hydroxyapatitbasierenden-filler-fuer-dieweichteilaugmentation-im-gesicht/. Accessed July 2023.
  7. Park, S. (2014). Investigation of the degradation-retarding effect caused by the low swelling capacity of a novel hyaluronic acid filler developed by solid-phase crosslinking technology. Annals of Dermatology, 26(3), 357. doi:10.5021/ad.2014.26.3.357
  8. Braz, A. (2024). A retrospective analysis of safety in participants treated with a hybrid hyaluronic acid and calcium hydroxyapatite filler. Plastic and Reconstructive Surgery - Global Open, 12(2). https://doi.org/10.1097/gox.0000000000005622
  9. ฆพ.3310/2567
  10. Allergan Aesthetics HArmonyCa™ Lidocaine Box August 2023

    Contraindications of HArmonyCa Lidocaine: Do not inject in cases of known sensitivity to any product components. Avoid use in patients with skin diseases, infections, inflammation at or near the treatment site. Contraindicated for those prone to keloids, hypertrophic scarring, or inflammatory skin conditions. Avoid in patients with impaired wound healing due to systemic disorders or certain medications. Do not use in patients with prolonged bleeding or poor tissue healing, history of anaphylactic reactions, or multiple severe allergies. Allergies to steroids or lidocaine (amide-type local anesthetics) also contraindicate use. Avoid injection in glabellar, periocular areas, lips, perioral region, regions with foreign bodies, blood vessels, highly vascularized areas, epidermis, and superficial dermis. Not suitable for patients with herpes, autoimmune diseases, breastfeeding, pregnant women, or those under 18. Precautions of HArmonyCa Lidocaine: Only to be used by authorized medical practitioners per local regulations. Single-use on one patient only; do not re-sterilize. Use under sterile conditions and before the expiration date. Do not use if the package is open, tampered with, or suspected of damage; discard damaged devices. Clinical judgment is required for the application, following sound medical practices. Caution in patients with a history of herpes, recent dental treatments, infections, or on immunosuppressive therapy. Be cautious near other dermal fillers, especially in marionette lines and oral commissures; do not overcorrect to avoid material migration. Allow 4 weeks between this and ultrasound-based, laser, or peeling treatments. Mild discomfort may occur; consider anesthetics following common practice.